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COPDAbstract This study examines the effect of self-education on, exercise tolerance, and dyspnea.
Twenty patients with stable COPD (mean forced expiratory volume in one second
FEV1 = 1.29 ± 0.28, 6MWD 333.15 ± 70, BAI43.15 ± 3.47) had seven 90 min sessions of self-
education at weekly intervals.
Patients completed the Beck Anxiety Inventory (BAI), one day before and seven weeks after
therapy. FEV1, forced vital capacity (FVC), blood gas tensions and six minute walking distance
(6MWD) are measured.
Twenty control patients attended weekly, they were assessed using spirometer and 6MWD was
measured for seven weeks. There were no differences in mean baseline age, (BAI) score, lung func-
tion, blood gas tensions or 6MWD between groups.
After treatment, the BAI score had decreased signiﬁcantly to 40.8 ± 3.11, in association; the
mean 6MWD had also improved in the treated group only, from 333.15 ± 70 to 376.9 ± 64.9
meter, an increase of statistically signiﬁcant p value of 0.042.
In conclusion: Seven week self-management education to COPD patients produced a signiﬁcant
improvement in exercise tolerance and BAI score.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Chronic obstructive pulmonary disease (COPD) is a serious
public health problem worldwide. The prevalence, morbidity,
and mortality are expected to rise, especially in countries with
a rapidly aging population and even in populations with re-
duced smoking rates [1–3]. A study published by the World
Bank/World Health Organization reported that COPD is
likely to rise from being the twelfth most burdensome disease
in 1990 to the ﬁfth in 2020 [4]. This will place an enormous
burden on the healthcare system and will cause a loss in health
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Treatment for COPD is often primarily aimed at improving
airﬂow obstruction by bronchodilator and anti-inﬂammatory
therapy, despite indications that airﬂow obstruction is irrevers-
ible and there is an apparent lack of effect of pharmacological
interventions on the progressive decline in health status.
Despite optimal pharmacological treatment, many patients
with COPD experience substantial functional impairment
[5,6]. However, airﬂow obstruction correlates poorly with
disease perception by the patient [7,8]. COPD is a systemic
inﬂammatory disease and, besides airﬂow limitation and
hyperinﬂation due to loss of elastic recoil and intrinsic airway
narrowing, systemic deﬁcits such as skeletal and respiratory
muscle dysfunction are prominent features. There is a growing
need for other forms of treatment for COPD patients, not only
to control and alleviate symptoms and complications of respi-
ratory dysfunction but also to teach them how to carry out the
activities of daily living optimally in the face of their physio-
logical impairment [9].
As regards asthma, patient education and self-management
programs have proved to be successful at least when combined
with a regular review in reducing the economic burden of the
disease and in improving quality of life and lung function
[10–14]. In COPD, pulmonary rehabilitation has been shown
to increase exercise tolerance and quality of life [15]. The draw-
back is that pulmonary rehabilitation programs will normally
be more expensive and time consuming for both professionals
and patients than self-management programs, and may be less
widely available.
Worth and colleagues [16] were the ﬁrst to describe the
effectiveness of a program aimed at acquiring self-management
skills and behavioral changes by patients with COPD. Unfor-
tunately this pilot study was uncontrolled and studied only a
small sample of patients (n= 21). Impressive reductions in
the frequency of exacerbations and home visits by the family
doctor were observed, but no changes in lung function were
found. Several controlled trials have been conducted to evalu-
ate the effectiveness of COPD education and self-management
education programs [17]. This review was conducted to exam-
ine the impact of these programs on health outcomes and
healthcare utilization.
6MWD is a practical ﬁeld test but its correct interpretation
is more debatable [18]. Studies have used the absolute value in
meters to determine its prognostic ability or its responsiveness
to pulmonary rehabilitation [19] or lung reduction surgery [20].
However, it is well known that the 6MWD is inﬂuenced by
age, sex and height. Indeed, the two studies validated herein,
have provided reference equations based on the testing of nor-
mal individuals and then expressed the observed results as a
percentage of predicted normal [21,22].Figure 1 Box Whisker plot of the 6MWT values between
treatment and control groups.Subjects and methods
20 patients with stable COPD scores of P22 for anxiety on
BAI scoring participated in the study, further 20 patients,
matched for severity of dyspnea and disability, were chosen
and agreed to act as controls. Exclusion criteria for patient
are chest infection within 1 month of the start of the study.
Bronchodilators were omitted four hours before initial mea-
surements on each day of the test .Verbal informed consent
was accepted from all participants.All patients enrolled in the study completed Beck Anxiety
Inventory (BAI) questionnaires in the chest clinic at New
Jeddah Hospital. The BAI (Beck AT and Steer RA, 1990) is
a self-administered questionnaire, comprising 21 questions
aimed to detect the severity of anxiety.
Control group: Patients attended seven times, at weekly
intervals for seven weeks aiming to give them some reason to
attend the Chest Clinic for the same number of times as the ac-
tive treatment group, FEV1, FVC and 6MWD, arterial blood
gases and BAI scores were measured during each visit at base-
line and week seven.
The results from day one and week seven were compared
with those from the active treatment group on baseline and
post therapy days (Fig. 1).
Education
The education method allowed COPD patients to attend lec-
tures once a week, for seven weeks each for 60–90 min to meet
the pulmonologist, psychiatrist and the internist.
The education contents:
(1) Explain the causes, symptoms, and predisposing factors
to COPD patients.
(2) Guide patients to make effective cough, breathing exer-
cises, abdominal breathing method, and enable patients
to demonstrate, the method correct.
(3) Guide patients on oxygen therapy methods and
precautions.
(4) Guide the patient to a proper diet, and instructed
patients that a proper diet is an important role in the
treatment of disease.
(5) Stress the method of medication, time, and inform the
importance of continued drug use.
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to work and rest balance.
(7) Add cloth when the weather cools to prevent and avoid
cold.
(8) Instruct patients to try not to go to crowded public
places.
(9) Understand the patient’s psychological changes, and
help patients to resolve the disease to their psychological
pressure in time.
(10) Guide families’ supervision of the implementation of
self-management education for patients. In addition,
they were given homework: breathing and relaxation
exercises for 10 min three times daily.
The statistical paragraph in material and methods
Data were statistically described in terms of mean ± standard
deviation (±SD), median and range, or frequencies (number
of cases) and percentages when appropriate. Comparison of
numerical variables between the study groups was done using
Student t test for independent samples. For comparing cate-
gorical data, Chi-square (v2) test was performed. Exact test
was used instead when the expected frequency is less than 5.
p values less than 0.05 were considered statistically signiﬁcant.
All statistical calculations were done using computer programs
SPSS (Statistical Package for the Social Science; SPSS
Inc., Chicago, IL, USA) version 15 for Microsoft Windows
(Table 1).
Results
Mean age was (64.45) ±4.92 y in the treatment group and
(67.30) ±6.09 y for controls. Mean ± SD baseline forced expi-
ratory volume in the ﬁrst second (FEV1) was (1.28) ±0.24 for
the treatment group and (1.29) ±0.28 for controls.
Comparing treatment group with controls, there were no
signiﬁcant differences in lung function or blood gas tensions,
neither at the start of treatment nor at the end of it
(Table 2).The scores from BAI were comparable between
groups on baseline 40.8 ± 3.1and 43.15 ± 3.74 for the treat-
ment and control group respectively (Table 2).
In the control group, none of the physiological or psycho-
logical measures altered signiﬁcantly during the study. OnTable 1 Report.
Group Age FEV1L FV
Treatments Mean 64.45 1.2895 2.9
N 20 20 20
Std. deviation 4.925 0.24916 0.3
Minimum 58 0.90 0.9
Maximum 74 1.75 1.7
Median 63.00 1.2400 1.2
Controls Mean 67.30 1.2995 2.7
N 20 20 20
Std. Deviation 6.097 0.28616 0.8
Minimum 56 0.95 2.2
Maximum 78 1.80 3.5
Median 67.50 1.2100 2.6
p value 0.112 0.9068 0.0the other hand, in the active treatment group, psychological
test (BAI) scores were signiﬁcantly different at the end of psy-
chotherapy compared to baseline values (t= & p 6 0.001). In
concordance the mean 6MWD increased very signiﬁcantly
from 333.15 ± 70 meter at baseline to 376.9 ± 64.9 meter
after psychotherapy (t & p< 0.001).
The difference in BAI scores at 7 weeks compared with con-
trols was also statistically signiﬁcant (p< 0.001) (Table 3)
There was no signiﬁcant difference in sex in both groups
(Table 2).Discussion
COPD is a disease that impairs functional capacity. However,
the degree of exercise intolerance as measured by the 6MWD
test varies widely even among patients with similar airﬂow lim-
itation. This was evident in large clinical trials such as those of
patients enrolled for lung volume reduction surgery [23], who
by design had a narrow range of airﬂow limitation but a wide
range of exercise performance. The exact reason for exercise
limitation in COPD is not fully understood but appears to
be somewhat independent of FEV1. In the majority of patients
with COPD, dyspnea is a main limiting factor [24], likely re-
lated to hyperinﬂation [25,26] airﬂow limitation [27] and
impairment in diffusing capacity [28]. In addition, skeletal
muscle dysfunction has also been implicated in the genesis of
exercise limitation among patients with COPD [29]. The mus-
cle of COPD patients shows structural and metabolic abnor-
malities, not seen in normal patients of similar age [19,30,31].
Whatever the exact reasons for exercise limitation, the evalua-
tion of exercise capacity using the 6MWD in patients with
COPD helps assess disease severity. Furthermore, identifying
levels of exercise impairment helps with the characterization
of these patients and assists with the referral to programs such
as pulmonary rehabilitation, lung reduction surgery or lung
transplantation.
Pulmonary rehabilitation provides an important treatment
option for patients with dyspnea due to severe COPD
[32,33]. The main components of rehabilitation were educa-
tion, breathing training exercises, systemic exercises, pharma-
cological and oxygen treatment, and patient support groups
[34,35]. Although, the importance of psychological support
as part of rehabilitation has increasingly been emphasized
recently [36–38] there is little published information on theCL PaO2 PaCO2 6MWDM BAIscore
5 76.490 43.355 376.10 40.80
20 20 20 20
8 1.3742 0.9578 64.953 3.122
0 73.9 42.1 244 36
5 79.3 45.2 500 47
400 76.250 43.050 383.00 41.00
3 74.220 43.130 331.15 43.15
20 20 20 20
1 0.8924 0.9056 70.052 3.746
0 73.0 41.4 224 36
5 76.1 44.6 460 49
250 73.950 42.950 327.50 44.00
000 0.000 0.450 0.042 0.038
Table 2 Male and female percentage in two groups.
Group
Controls Treatment
Sex F Count 7 8
% within Group 35.0% 40.0%
M Count 13 12
% within Group 65.0% 60.0%
p value 0.744
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vere COPD patients.
The two studied groups in this study were well matched in
terms of lung function, walking distance, and BAI scores.
Ninety percent of the treatment group had severe anxiety
scores of P35, while 80% of the control patients had anxiety
scores above 35. As we match patients for BAI scores in order
to make the comparison more complete, the control patients
were being selected mainly for comparable disability in terms
of breathlessness and anxiety.
The BAI scores improved after therapy, and all patients
who completed the course of treatment claimed to feel more re-
laxed and generally better. In contrast to our ﬁnding, in the
study of [39] surprisingly, he found that the anxiety scores
did not improve after therapy, but in his study the HADS anx-
iety scale was used to assess the degree of anxiety and it is pos-
sible that the HADS score is not sensitive enough to have
detected any changes achieved. In addition, the sessions in
the study by Eiser et al. [40], and Funk et al. [41] concentrated
particularly on education, muscle relaxation and breathing
exercises, whereas in the present study the psychiatrist concen-
trated more on exploring the roots of the patients’ anxieties
and developing general psychological coping strategies. The
breathing exercises were directed predominantly at general
relaxation rather than training of muscle groups. Generally,
we are in agreement with Atkins et al. [42], and Puhan et al.
[43] who mentioned that a much longer rehabilitation pro-
gram, including psychological sessions, was more effective in
reducing anxiety than rehabilitation sessions alone [44].
The signiﬁcant effect of the psychotherapy and education
on reducing anxiety level in the present study was reﬂected
on the increase in exercise tolerance, which was evident after
treatment. The 6MWD test proved a reliable and reproducible
method for assessing exercise tolerance [45]; Eieser et al. [46]Table 3 Effects on lung function, arterial blood gas tensions, 6 m
groups.
Treatment group
Baseline 7-Week post-Rx
FEV1 L 1.29 ± 0.28 1.29 ± 0.25
FVC L 2.77 ± 0.39 2.95 ± 0.38
6MWD m 333.15 ± 70 376.9 ± 64.9**
PaCO2 43.13 ± .90 43.35±.95
PaO2 74.22 ± .89 76.94 ± 1.37
BAI score 43.15 ± 3.74 40.8 ± 3.11**
Values are presented as mean ± SD. Post-Rx: post-therapy.
** p< 0.05, compared to control group after 7 weeks (unpaired t-test).proved the improvement in six MWD, was sufﬁcient to pro-
duce a signiﬁcant difference from the baseline measurement
and when compared with controls (Table 3). This signiﬁcant
effect of the psychotherapy and education on increasing the
exercise tolerance in patients with COPD was found in another
study [39] which was partly sustained at 3 months after treat-
ment. Nevertheless, according to the study of Eiser et al. the
improvement in exercise tolerance, though highly statistically
signiﬁcant, was not related to the HADS scores. Again, the po-
sitive outcome in our study is best attributed to the differences
in style and content of the sessions, which produced interesting
results in terms of improvement in cognitive style and coping
mechanisms rather than just improving the exercise capacity.
In agreement with our explanation, Sassi et al. [47] found a
signiﬁcant improvement in the transitional dyspnea index in
patients with COPD who received proper cognitive psycho-
therapy. He found that in 6 months after treatment with psy-
chotherapy patients, with dyspnea for any cause, who were
taught coping strategies by a psychotherapist, would respond
better to treatment than patients who had general education
sessions alone [42].
Regarding the improvement in pulmonary function, in the
present study, there was no change either in lung function or
in arterial blood gas tensions. We may need a further larger
study with a longer and/or more intensive course of psycho-
therapy and education programs in order to establish whether
any improvement in pulmonary function or ABG could be
achieved.In conclusion
A seven-week course of self-management education, cognitive
and behavioral psychotherapy from psychiatrists produced a
signiﬁcant improvement in exercise tolerance in anxious,
breathless patients with chronic obstructive pulmonary dis-
ease, because of signiﬁcantly alleviating their anxiety and
improving their self-management styles. Much larger numbers
of patients would be required to establish whether this ap-
proach to treatment would be worthwhile routinely in the clin-
ical setting.Conﬂict of interest
None declared.in walking distance (6MWD) and anxiety scores between two
Control group
p Baseline 7-Weeks p
0.90 1.34 ± 0.39 1.25 ± 0.37 0.66
0.33 2.73 ± 0.81 2.76 ± 0.23 0.91
0.042 358.2 ± 31.3 367.8 ± 76. 0.09
0.45 43.42 ± 1.22 43.90 ± 1.3 0.90
0.75 76.70 ± 2.23 75.89 ± 2.1 0.16
0.038 40.8 ± 4.2 40.1 ± 7.8 0.94
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